These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23650141)

  • 1. How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity?
    Xie J; Erneux C; Pirson I
    Bioessays; 2013 Aug; 35(8):733-43. PubMed ID: 23650141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C; Edimo WE; Deneubourg L; Pirson I
    J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
    Eramo MJ; Mitchell CA
    Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
    Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
    Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
    Erneux C; Govaerts C; Communi D; Pesesse X
    Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
    FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
    Astle MV; Horan KA; Ooms LM; Mitchell CA
    Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2-containing 5'-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor.
    Prasad NK; Decker SJ
    J Biol Chem; 2005 Apr; 280(13):13129-36. PubMed ID: 15668240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
    Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
    Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
    Edimo WE; Janssens V; Waelkens E; Erneux C
    Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
    Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
    Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous SHIP2 does not localize in lipid rafts in 3T3-L1 adipocytes.
    Jacobs C; Onnockx S; Vandenbroere I; Pirson I
    FEBS Lett; 2004 May; 565(1-3):70-4. PubMed ID: 15135055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
    J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
    Elong Edimo W; Vanderwinden JM; Erneux C
    Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.